Inicio › Enfermedad de Crohn › Nueva York
Ensayos clínicos de Enfermedad de Crohn en Nueva York
36 estudios sobre Enfermedad de Crohn buscan participantes en Nueva York.
Ciudades en Nueva York
Texto oficial del estudio (inglés)
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Westchester Putnam Gastroenterology PC, Carmel
- Five Towns Gastroenterology, Cedarhurst
- IMIDeology, Elmhurst
- y 5 más
ReclutandoFase 4
Edades de 18 a 80 · Todos los sexos · Actualizado el 30 sept 2026 · NCT06581328A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Northwell Health Physician Partners Center for Advanced IBD Care ( Site 5017), Great Neck
- NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 5078), New York
- Weill Cornell Medical College, New-York Presbyterian Hospital ( Site 5079), New York
- y 2 más
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 29 sept 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- New York Gastroenterology Associates - Upper East Side /ID# 281767, New York
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 29 sept 2026 · NCT07697456A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Westchester Putnam Gastroenterology, Carmel
- Inflammatory Bowel Disease Center at NYU Langone, New York
- Weill Cornell Medical College, New York
- y 2 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07196722A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Westchester Putnam Gastroenterology, Carmel
- New York Gastroenterology Associates, New York
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07499232A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Weill Cornell Medical College - Judith Jaffe Multiple Sclerosis Center, New York
- Icahn School of Medicine at Mount Sinai, New York
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 25 sept 2026 · NCT05923073A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH), New York
- Rochester Clinical Research, Inc, Rochester
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06233461Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Nyu Langone Long Island Clinical Research Associates - Lake Success /ID# 265566, Lake Success
- Northwell Health-Lenox Hill Hospital /ID# 265527, New York
- Care Access - Yonkers /ID# 266781, Yonkers
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06548542Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- New York Gastroenterology Associates, New York
- Care Access - Yonkers, Yonkers
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06937099An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- MedTraits NY-Site Number: 8400045, Maspeth
- Manhattan Clinical Research, LLC-Site Number: 8400069, New York
- NYU Langone Health-Site Number: 8400091, New York
- y 4 más
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 23 sept 2026 · NCT07184931A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Icahn School of Medicine at Mount Sinai /ID# 254880, New York
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 23 sept 2026 · NCT05995353A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- MedTraits NY-Site Number: 8400045, Maspeth
- NYU Langone Health-Site Number: 8400091, New York
- Weill Cornell Medicine - NewYork-Presbyterian Hospital-Site Number: 8400040, New York
- y 1 más
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 23 sept 2026 · NCT07184944Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- y 1 más
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT03816345A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Icahn School of Medicine at Mount Sinai, New York
ReclutandoFase 3
Edades de 2 a 19 · Todos los sexos · Actualizado el 22 sept 2026 · NCT04844606A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- NYU Langone Health, New York
ReclutandoFase 4
Edades de 18 a 70 · Todos los sexos · Actualizado el 9 sept 2026 · NCT06045754Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- New York Gastroenterology Associates ( Site 0253), New York
ReclutandoFase 3
Todas las edades · Todos los sexos · Actualizado el 9 sept 2026 · NCT06651281Standardized Microbiota Transplant Therapy in Crohn's Disease
- NYU Langone Health, New York
ReclutandoFase 2
Edades de 18 a 89 · Todos los sexos · Actualizado el 8 sept 2026 · NCT06631586A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- New York Gastroenterology Associates, New York
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 ago 2026 · NCT07577843A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC), New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center/New York Presbyterian, New York
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 24 ago 2026 · NCT05509777Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
- Weill Cornell Medicine, New York
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 ago 2026 · NCT06274554Behavioral Therapy for Crohn's Disease
- Icahn School of Medicine at Mount Sinai, New York
- New York Gastroenterology Associates, New York
Reclutando
Edades de 18 a 65 · Todos los sexos · Actualizado el 12 ago 2026 · NCT06512597Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Saratoga Schenectady Gastroenterology Associates, Burnt Hills
- NYU Langone Health, New York
- Cornell University, New York
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 ago 2026 · NCT05230173Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- New York University, New York
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT07237516Low Dose IL-2 for the Treatment of Crohn's Disease
- Mount Sinai, New York
ReclutandoFase 1/2
Edades de 12 a 80 · Todos los sexos · Actualizado el 3 ago 2026 · NCT04263831Autologous Stem Cell Transplant for Crohn's Disease
- Icahn School of Medicine at Mount Sinai, New York
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 jul 2026 · NCT03219359Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
- Icahn School of Medicine at Mount Sinai /ID# 262216, New York
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 24 jun 2026 · NCT06332534A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- New York Presbyterian Hospital, New York
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 22 jun 2026 · NCT06405087Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
- Icahn School of Medicine at Mount Sinai, New York
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 5 jun 2026 · NCT06976853Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Cohen Children's Medical Center of NY, Lake Success
- Columbia University Medical Center, New York
ReclutandoFase 4
Edades de 6 a 17 · Todos los sexos · Actualizado el 27 may 2026 · NCT05781152A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- Columbia University Medical Center, New York-Presbyterian Hospital, New York
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 27 may 2026 · NCT06227910Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis
- Weill Cornell Medical College, New York
Reclutando
Edades de 18 a 90 · Todos los sexos · Actualizado el 14 may 2026 · NCT03256240A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- The Steven and Alexandra Cohen Childrens Medical Center of New York - BRANY - PPDS, New Hyde Park
- Stony Brook University Medical Center, Stony Brook
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 5 may 2026 · NCT04779320A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, New York
- Mirador Therapeutics Selected Site, Rochester
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 12 mar 2026 · NCT07113522Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
- Icahn School of Medicine at Mount Sinai, New York
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 ene 2026 · NCT06001450Treatment of Moderate to Severe Refractory Crohn's Disease
- Mount Sinai Health Systems, New York
ReclutandoFase 1/2
Edades de 18 a 65 · Todos los sexos · Actualizado el 10 dic 2025 · NCT06721962Helmsley 3.0: Abbreviated MRE
- NYU Langone, New York
ReclutandoEstudio observacional
Edades de 10 en adelante · Todos los sexos · Actualizado el 27 oct 2025 · NCT06533228De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.